How best to forecast the uptake of new pharmaceuticals: Cell and gene therapies
Whether you are forecasting the uptake of a new cell and gene therapy or its impact on existing chronic therapies, there are two major headwinds. First, one-off treatments such as cell and gene therapies eliminate their own treatable patient pool. Second, the uncertainty of a cell and gene therapy’s long-term effectiveness. In this paper, we […]
Read More